Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1
1(50.0%)
Phase 2
1(50.0%)
2Total
Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04973046Completed

Tissue Oxygen Saturation for Esophagectomy

Role: lead

NCT04683601Completed

Generation of a Surgical Field in the Left Lateral Decubitus Position

Role: lead

NCT04597398Completed

Utility of the Evaluation of Blood Flow of the Remnant Esophagus in Esophagectomy With Pedicled Jejunum Reconstruction

Role: lead

NCT01504997Phase 2Unknown

Phase II Study for Robot Assisted Distal Gastrectomy

Role: lead

NCT00524706Phase 1Unknown

Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer

Role: lead

All 5 trials loaded